Largest Shareholder Lee Yun-woo Increases Stake from 38.67% to 39.67% via Open Market Purchases, Signaling Strengthened Control


  • Largest shareholder Lee Yun-woo and special relations increased their combined stake from 38.67% to 39.67% (up 1.00%p) through open market purchases, acquiring 60,167 additional shares.
  • Lee himself bought 56,609 shares (0.94%), while special relations Lee Seung-young, Lee Seung-yeon, An Hye-ryeong, and An Hyun-cheol made small purchases; Jo Young-ki sold 13,500 shares.
  • The stake increase, driven by the largest shareholder's voluntary buying, can be interpreted as a signal of strengthened control and support for the stock price.
  • All acquisition funds were sourced from personal funds (salary and self-funding), indicating low financial burden.
  • [AI Comprehensive Analysis]The marginal stake increase is unlikely to have a significant short-term price impact, but the largest shareholder's accumulation is a positive signal for governance stability. Without additional measures like share buybacks or dividend hikes, market reaction is expected to be limited.

KOSDAQ Filing Information


  • Filing: Report on Large Shareholding (General)
  • Company: DaehanPharmaceutical (023910)
  • Submission: Lee Yun-woo
  • Receipt: 05-28-2026